Idorsia Pharmaceuticals Ltd
+41 58 844 00 00
Please get in touch with us via the contact form by clicking "Next".
Learn more about our Governance by clicking "Next"
Idorsia attempts to ensure that your Personal Data are updated, accurate, and complete according to the information that has been provided. Any request related to the exercise of your privacy rights can be sent through the link below.
To best serve your interest, Idorsia offers an electronic ‘Stay Informed’ service. With this service you have the possibility to automatically receive Idorsia's Media Releases directly to your inbox. In addition, if you provide your mobile phone number, we will send you an alert via SMS when the media release is published.
Investor community: To make your job easier the Results Day Center is your one-stop-shop for all relevant documentation for our quarterly financial reporting.
Investor community: Idorsia represents a unique opportunity, with all the key ingredients to reach out for more! In this section you will find information about our ambitious goals.
Investor community: Get all the details on our curent financial situation as well as supporting archive financial information.
Investor community: Providing comprehensive and timely information to our shareholders is important to us. You can find a full archive of our corporate reports on this page.
Investor community: Get an overview of when we have the next financial reporting, most recent media releases, and an archive of our investor webcasts.
The registered shares of Idorsia Ltd were listed on the SIX Swiss Exchange on June 16, 2017 (symbol: IDIA). Following the transfer of Actelion’s drug discovery and early-stage clinical pipeline business to Idorsia, registered Idorsia shares held by Actelion have been distributed to Actelion shareholders by way of a dividend in kind.
Investor community: Sound corporate governance and high standards of ethical behavior are essential to company success, learn more about our approach to corproate governance and sustainability.